UY27442A1 - USE OF A COMBINATION OF COMPOUNDS IN A DRY POWDER INHALER. - Google Patents

USE OF A COMBINATION OF COMPOUNDS IN A DRY POWDER INHALER.

Info

Publication number
UY27442A1
UY27442A1 UY27442A UY27442A UY27442A1 UY 27442 A1 UY27442 A1 UY 27442A1 UY 27442 A UY27442 A UY 27442A UY 27442 A UY27442 A UY 27442A UY 27442 A1 UY27442 A1 UY 27442A1
Authority
UY
Uruguay
Prior art keywords
compounds
combination
formula
dry powder
powder inhaler
Prior art date
Application number
UY27442A
Other languages
Spanish (es)
Inventor
Michael J Humphrey
Paul R Miller
Michael T Shepherd
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to UY27442A priority Critical patent/UY27442A1/en
Publication of UY27442A1 publication Critical patent/UY27442A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una formulación de inhalación que comprende una combinación de un compuesto seleccionado entre una clase particular de 5,6-dihidro-9H-pirazolo(3,4-c)-1,2,4-triazolo(4,3-a)piridinas de fórmula (I) y una sal tiotropio o solvato de cualquiera de ellos, que es capaz de liberar el compuesto de fórmula (I) en forma de partículas sólidas finas en el pulmón. La invención también incluye el uso de tal formulación en el tratamiento de ciertas enfermedades tales como las enfermedades respiratorias y los compuestos que son útiles en la invención son los compuestos de fórmula (I),y las sales farmacéuticamente aceptables de los mismos.The present invention relates to an inhalation formulation comprising a combination of a compound selected from a particular class of 5,6-dihydro-9H-pyrazolo (3,4-c) -1,2,4-triazolo (4, 3-a) pyridines of formula (I) and a tiotropium or solvate salt of any of them, which is capable of releasing the compound of formula (I) in the form of fine solid particles in the lung. The invention also includes the use of such a formulation in the treatment of certain diseases such as respiratory diseases and the compounds that are useful in the invention are the compounds of formula (I), and pharmaceutically acceptable salts thereof.

UY27442A 2002-09-10 2002-09-10 USE OF A COMBINATION OF COMPOUNDS IN A DRY POWDER INHALER. UY27442A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY27442A UY27442A1 (en) 2002-09-10 2002-09-10 USE OF A COMBINATION OF COMPOUNDS IN A DRY POWDER INHALER.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY27442A UY27442A1 (en) 2002-09-10 2002-09-10 USE OF A COMBINATION OF COMPOUNDS IN A DRY POWDER INHALER.

Publications (1)

Publication Number Publication Date
UY27442A1 true UY27442A1 (en) 2003-04-30

Family

ID=38812688

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27442A UY27442A1 (en) 2002-09-10 2002-09-10 USE OF A COMBINATION OF COMPOUNDS IN A DRY POWDER INHALER.

Country Status (1)

Country Link
UY (1) UY27442A1 (en)

Similar Documents

Publication Publication Date Title
CO2022001357A2 (en) Pyrazolo[3,4-b]pyrazine-type shp2 phosphatase inhibitors
UY28896A1 (en) POWDER FORMULATIONS FOR INHALATION, WHICH CONTAIN BETA-ENANTIOMERALLY PURE AGONISTS
AR055669A1 (en) DERIVATIVES OF 3H - IMIDAZO [4, 5 -B] PIRIDINE AS SELECTIVE INHIBITORS OF GSK3, METHODS AND INTERNEDIARIES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF NEURODE DISEASE.
ECSP055774A (en) NEW MEDICATION FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
TW200626153A (en) Heterocyclic derivatives and their use as therapeutic agents
AR054347A1 (en) THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION
ECSP066383A (en) DERIVATIVES OF 5-PHENYL-4-METHYL-TIAZOL-2-IL-AMINA AS INHIBITORS OF KINASA ENZYMES PHOSFATIDILINOSITOL 3 (PI3) FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE RESPIRATORY ROUTES
TW200624427A (en) Heterocyclic derivatives and their use as therapeutic agents
TW200626139A (en) Heterocyclic derivatives and their use as therapeutic agents
TW200626592A (en) Heterocyclic derivatives and their use as therapeutic agents
TW200626154A (en) Heterocyclic derivatives and their use as therapeutic agents
AR036474A1 (en) USE OF A COMPOUND COMBINATION IN A DRY POWDER INHALER
TW200626155A (en) Heterocyclic derivatives and their use as therapeutic agents
JP2015506348A5 (en)
ECSP045253A (en) DERIVATIVES OF 5-PHENYLTIAZOL AND USE AS INHIBITORS OF PI3 CINASA
TW200626572A (en) Heterocyclic derivatives and their use as therapeutic agents
AR046297A1 (en) DPP INHIBITORS - IV METHODS TO PREPARE THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AS ACTIVE AGENTS
ECSP066948A (en) BENZOXAZINES FOR THE TREATMENT OF RESPIRATORY ROAD DISEASES
UY28369A1 (en) THERAPEUTIC AGENTS
CO2019004190A2 (en) Liposomal formulations for use in cancer treatment
ECSP067111A (en) DERIVATIVES OF PIRIDO-PIRIMIDINA, ITS PREPARATION, ITS APPLICATION IN THERAPEUTICS
AR037681A1 (en) ADENOSINE A2A RECEIVING ANTAGONISTS OF 5-AMINO- [1,2,4] -BICYCLIC TRIAZOL, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, THE USE OF THE SAME, ONLY OR IN COMBINATION OF THE COMPOUNDS AND OTHER AGENTS FOR THE PREPARATION OF MEDICINES UTI THE TREATMENT OF PARKINSON'S DISEASE AND A
PE20211805A1 (en) FORMULATIONS OF AN AXL / MER INHIBITOR
UY27980A1 (en) INDOLES 2,7-REPLACED
UY27442A1 (en) USE OF A COMBINATION OF COMPOUNDS IN A DRY POWDER INHALER.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20141217